Angiotensin receptor-neprilysin inhibition and combination use of guideline-directed medical therapies in acute heart failure
Eur J Heart Fail
.
2024 Nov 11.
doi: 10.1002/ejhf.3526.
Online ahead of print.
Authors
Atsushi Tanaka
1
,
Takumi Imai
2
3
,
Keisuke Kida
4
,
Yuya Matsue
5
,
Koichi Node
1
;
on behalf of the PREMIER Study Investigators
Affiliations
1
Department of Cardiovascular Medicine, Saga University, Saga, Japan.
2
Clinical Research Division, Organization for Clinical Medicine Promotion, Tokyo, Japan.
3
Clinical and Translational Research Center, Kobe University Hospital, Kobe, Japan.
4
Department of Pharmacology, St. Marianna University School of Medicine, Kawasaki, Japan.
5
Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
PMID:
39523914
DOI:
10.1002/ejhf.3526
No abstract available